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After entering a cell during infection, the human immuno-
de¢ciency virus type 1 (HIV-1) undergoes a series of steps
including reverse transcription of its genome and culminating
in integration of proviral DNA into the host chromosomes.
The further fate of the individual provirus is to a great extent
in£uenced by the e⁄ciency of provirus transcription, depen-
dent upon the site of its integration [1]. How HIV-1 and other
retroviruses choose their integration sites is still far from com-
pletely understood. It seems that the integration is not strictly
speci¢c, because most or all genomic regions are potential
targets, but neither is it a random event. Locally, there are
up to several hundred-fold di¡erences in the usage of target
sites due to the local DNA structure, bending, distortion and
wrapping around nucleosomes (reviewed in [2]).
The non-randomness on the scale of genomic regions has
been much less addressed [3]. Methods employed to study in
vivo retrovirus integration sites include restriction enzyme di-
gestions and blotting, £uorescence in situ hybridization, PCR-
based assays, and most importantly cloning and sequencing
the virus^host integration junctions. Most studies analyze
only a small number of integration sites, or focus on selected
genomic regions. To date, the most representative study is
provided by Carteau et al. [4]. It lists a set of 61 HIV-1
integration site sequences obtained after short experimental
infection of the human T-cell line SupT1. Of these, 59 sequen-
ces are available in GenBank, together with 104 control ge-
nomic sequences for comparison. The authors analyzed the
sequences using the nr, dbEST and MONTH databases as
of November 1997. They concluded that there is no signi¢cant
di¡erence between integration sites and controls, except that
centromeric alphoid repeats are selectively absent at integra-
tion sites. The availability of the human genome sequence [5]
creates a great opportunity for a new genome-wide analysis of
these data. By mapping the exact positions of the integration
sites we can analyze large DNA regions £anking the provi-
ruses and describe the genomic features present.
We used the BLAT program to map the genomic positions
of integration sites in the most recent GoldenPath assembly of
6 August 2001 (http://genome.ucsc.edu). Of 59 sequences
available in GenBank, we succeeded in mapping 48, where
the level of homology was satisfactory (Table 1 in supplemen-
tary material on the web; http://www.elsevier.com/PII/
S0014579302026121). For each mapped integration we col-
lected several genomic features available in the GoldenPath
assembly. The ¢rst was the presence of transcribed sequences,
either as the ‘known protein coding genes’ category (from the
RefSeq project) or as the ‘human mRNAs from GenBank’
category. In addition, 800 cytogenetic band resolution is avail-
able, light or dark according to Giemsa staining. Next we
calculated the GC level of 100 kb regions surrounding the
integration sites symmetrically and the gene densities along
these £anking regions. We compared these data with the
whole genome summary statistics that we calculated for the
GoldenPath assembly and looked for any di¡erences indicat-
ing possible integration preference.
In our analysis, 54.2% (26 of 48) of the mapped integration
sites fall in genes, which is signi¢cantly higher compared to
the genome average calculated as 22.2% (P6 0.00001, M2 test).
For the broader category of mRNAs this comparison is 68.7%
to 30.7% (P6 0.00001, M2 test). This implies that potentially
transcribed regions represent strongly preferred targets for
HIV-1 integration. Out of the 33 integrations in transcription
units, 18 and 15 are in sense and antisense orientation, respec-
tively, 28 map to introns, two to exons, two to 5P untranslated
regions (UTR) and one to a 3P UTR. Giemsa light (R) and
dark (G) bands were targeted in 68.7% and 31.2%, compared
to genome averages of 44.0% and 48.5%, respectively, esti-
mated from the GoldenPath assembly (P6 0.003, M2 test).
The average GC content of 100 kb regions £anking the inte-
gration sites was calculated to be 44.4%, higher than the
whole genome average of 41.0%. The distribution of integra-
tions is clearly biased, with more hits belonging to the GC-
richer genomic regions (Fig. 1).
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Fig. 1. Distribution of 48 HIV-1 integration sites in the human ge-
nome with respect to the GC content. On the horizontal axis, there
are 100 kb genomic regions arranged by their GC content, the
GC% intervals are consistent with the proposed division of the ge-
nome into ¢ve categories (isochores) [6]: L1 (6 37%), L2 (37^41%),
H1 (41^46%), H2 (46^52%) and H3 (s 52%). The vertical axis
shows the probability of targeting the individual classes with a
speci¢ed GC content. This is calculated as the number of integra-
tions whose 100 kb surrounding belongs to the corresponding GC%
interval divided by the extent occupied by the 100 kb genomic re-
gions also belonging to the same GC% interval. The size of the ge-
nome belonging to individual GC% categories in 100 kb windows is
571 Mb for L1, 977 Mb for L2, 706 Mb for H1, 321 Mb for H2
and 85 Mb for H3. The graph clearly shows an increasing tendency,
with higher probability that regions with higher GC content will be
targeted.
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To characterize the gene density, we calculated the average
number of entries of the ‘known genes’ category (5P ends) in
1 Mb regions surrounding the integration sites as 12.0. This is
several times higher than the genome average of 4.4 (estimated
as 14 200 entries in the ‘known genes’ category per 2.85 Gb
sequenced genome size). The means are signi¢cantly di¡erent
according to the Mann^Whitney U-test (P6 0.0001). We ob-
tained similar results for 100 kb regions and for the mRNA
category (data not shown).
Thus, it appears that HIV-1 preferably integrates into
genes, genome regions with increased gene density, cytoge-
netic light bands, and GC-rich regions. These features obvi-
ously are interdependent, genes being more frequent in GC-
rich regions and in Giemsa light bands, and light bands hav-
ing a higher average GC content than dark bands [6]. It is
possible that the preference for gene integrations causes the
bias observed for chromosomal bands and GC distribution.
The speci¢cations of genes targeted are available in the sup-
plementary material. It would be interesting to quantify their
expression in the SupT1 cell line used. The observed prefer-
ences support the model of favored integration into regions
with an open chromatin structure.
The share of gene integrations may further increase, be-
cause we consider only genes identi¢ed with high con¢dence
in the GoldenPath assembly, not genes predicted by computer
programs. On the other hand, we could not identify genomic
positions of 11 integration site sequences, not even in the
public Celera genome or in the draft HTGS sequences. These
presumably belong to the unsequenced or heterochromatin
portion of the genome and could weaken the statistical sig-
ni¢cance of gene targeting.
This is, to our knowledge, the ¢rst study that maps the
exact genomic positions of HIV-1 integrations. Previous ap-
proaches relied just on the short sequences obtained by PCR
or cloning and could not analyze larger £anking regions and
more distant genomic features. The reason why Carteau et al.
found only 18% integrations into transcription units was that
most introns targeted were not in the database at that time.
The features previously reported in HIV-1 integration sites
were described in a small number of cases, for example, the
presence of topoisomerase II cleavage sites was described
based on a single integration [7]. Broader analyses did not
reveal any signi¢cant preferences, except for the increased
number of Alu and L1 repeats, but this was not con¢rmed
later [4]. Even the most recent studies do not report any sig-
ni¢cant preferences of HIV-1 integration [8]. Also, most stud-
ies analyzed integrations in long-term cell lines or in patient
material. In such cases, the repeated cell divisions can select
for some infected clones with growth advantage or greater
provirus stability and the initial integration site distribution
can be disturbed. Carteau et al. harvested cells just 14 h post-
infection, thus avoiding this e¡ect. Most studies publish only
the sequence analysis, but Carteau et al. deposited all pub-
lished sequences in GenBank. All this prompted us to limit
our analysis to this homogeneous and most representative set
of data.
As to other retrovirus species, Moloney murine leukemia
virus was reported to integrate into transcriptionally active
genome regions in ¢ve of nine cases analyzed [9]. For avian
sarcoma leukosis virus RAV-1, the transcriptional activity of
one locus was found to be associated with a decrease in in-
tegration frequency [10]. Surveys of HTLV-I integrations did
not characterize any speci¢c preferred targets [11].
The preference of HIV-1 for transcriptionally active regions
with open chromatin conformation could be advantageous,
allowing higher transcription of the provirus and thus more
e⁄cient continuation of its replication cycle. However, disrup-
tion of some genes may be harmful to the host cell and this
may select against such integration events during subsequent
cell divisions. The mechanisms of the proposed integration
preference may involve just a greater accessibility of open
chromatin regions to the viral preintegration complex, or its
speci¢c nuclear localization. The integrase protein of HIV-1
also interacts with Ini1/hSNF5, a component of the chromatin
remodeling complex [12]. This interaction could actively target
the integrations to a subset of genomic locations favorable for
transcription.
Our approach demonstrates the advantage of using the hu-
man genome sequence for analyzing the pattern of retroviral
integration. Of further interest should be the analysis of more
integration events, including other retroviral genera, other cell
types, and, particularly, quiescent HIV-1-infected cells.
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